August 18, 2000
Some patients who have no approved drugs still effective for them choose to wait to start Kaletra until they can begin more than one experimental drug simultaneously.
From the August 4 release: "The Kaletra Early Access program is currently under way in 21 countries, and 6,100 patients are enrolled in the program, worldwide. Individuals interested in receiving Kaletra through early access should speak with their healthcare provider or call 1-888-711-7193 in the United States and Canada. Physicians who wish to request registration materials or additional information can call the same number."
ISSN # 1052-4207
Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
Back to the AIDS Treatment News August 18, 2000 contents page.